Drug Shortage Report for VINBLASTINE SULPHATE INJECTION

Last updated on 2021-01-07 History
Report ID 128028
Drug Identification Number 02401460
Brand name VINBLASTINE SULPHATE INJECTION
Common or Proper name VINBLASTINE SULFATE INJECTION 10MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VINBLASTINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-11-04
Estimated end date 2020-12-31
Actual end date 2021-01-06
Shortage status Resolved
Updated date 2021-01-07
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-01-07 French Compare
v3 2021-01-07 English Compare
v2 2020-11-06 French Compare
v1 2020-11-06 English Compare